Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: A prospective, pilot study

Alimentary Pharmacology and Therapeutics

Volumn 20, Issue 7, 2004, Pages 783-792

  Yamamoto, T ^a   Umegae, S ^a   Kitagawa, T ^a   Yasuda, Y ^a   Yamada, Y ^a   Takahashi, D ^a   Mukumoto, M ^a   Nishimura, N ^a   Yasue, K ^a   Matsumoto, K ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADULT; APHERESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ACTIVITY; FEMALE; FEVER; GRANULOCYTE; HEADACHE; HUMAN; LIVER DYSFUNCTION; MALE; MONOCYTE; PATIENT COMPLIANCE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; SAFETY; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; COLITIS, ULCERATIVE; CYTAPHERESIS; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FOLLOW-UP STUDIES; GRANULOCYTES; HUMANS; MALE; MIDDLE AGED; MONOCYTES; PATIENT COMPLIANCE; PILOT PROJECTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 4844231152     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.02189.x     Document Type: Article

References (26)

1. Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am 1999; 28: 255-81.
2. Truelove SC. Treatment of ulcerative colitis with local hydrocortisone. BMJ 1956; 2: 1267-72.
3. Mulder CJJ, Tytgat GNJ. Topical corticosteroids in inflammatory bowel disease. Aliment Pharmacol Ther 1993; 7: 125-30.
4. Ardizzone S, Porro GB. The topical treatment of distal ulcerative colitis. Eur J Gastroenterol Hepatol 1996; 8: 599-602.
5. Marshall JK, Irvine EJ. Rectal corticosterolds versus alternative treatments in ulcerative colitis: a meta-analysis. Gut 1997; 40: 775-81.
6. Vecchi M, Saibeni S, Devani M, et al. Review article: Diagnosis, monitoring and treatment of distal colitis. Aliment Pharmacol Ther 2003; 17 (Suppl. 2): 2-6.
7. Lee DAH, Taylor GM, James VHT, et al. Plasma prednisolone levels and adrenocortical responsiveness after administration of prednosolone-21-phosphate as a retention enema. Gut 1979; 20: 349-55.
8. Farmer RG, Achumacher OP. Treatment of ulcerative colitis with hydrocortisone enemas: relationship of hydrocortisone absorption, adrenal suppression, and clinical response. Dis Colon Rectum 1970; 13: 355-61.
9. Luman W, Gray RS, Pendek R, et al. Prednisolone metasulphobenzoate foam retention enemas suppress the hyothalamo-pituitary-adrenal axis. Aliment Pharmacol Ther 1994; 8: 255-8.
10. Danielsson A, Hellers G, Lyrenas E, et al. A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Scand J Gastroenterol 1987; 22: 987-92.
11. Grisham MB, Kvietys PR. Role of neutrophils in the pathogenesis of inflammatory bowel disease. In: Allan, RN, Rhodes, JM, Hanauer, SB, Keighley, MRB, Alexander-Williams, J, Fazio, VW, eds. Inflammatory Bowel Diseases, 3rd edn. New York: Churchill Livingstone, 1997: 73-80.
12. Mahida YR. Monocytes and macrophages in inflammatory bowel disease. In: Allan, RN, Rhodes, JM, Hanauer, SB, Keighley, MRB, Alexander-Williams, J, Fazio, VW, eds. Inflammatory Bowel Diseases, 3rd edn. New York: Churchill Livingstone, 1997: 81-5.
13. Rampton DS. Inflammatory mediators. In: Allan, RN, Rhodes, JM, Hanauer, SB, Keighley, MRB, Alexander-Williams, J, Fazio, VW, eds. Inflammatory Bowel Diseases, 3rd edn. New York: Churchill Livingstone, 1997: 107-16.
14. Fujimori J, Yoshino S, Koiwa M, et al. Improvement in rheumatoid arthritis following application of an extracorporeal granulotreap column, G-1. Rheumatol Int 1995; 15: 175-80.
15. Kashiwagi N, Hirata I, Kasukawa R. A role for granulocyte and monocytes apheresis in the treatment of rheumatoid arthritis. Ther Apher 1998; 2: 134-41.
16. Sawada K, Shimoyama T. Therapeutic cytapheresis for inflammatory bowel disease. Ther Apher 1998; 2: 90-2.
17. Rembacken BJ, Newbould HE, Richards SJ, et al. Granulocyte apheresis in inflammatory bowel disease: possible mechanisms of effect. Ther Apher 1998; 2: 93-6.
18. Shimoyama T, Sawada K, Hiwatashi N, et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apheresis 2001; 16: 1-9.
19. Kashiwagi N, Sugimura K, Koiwai H, et al. Immunomodulatory effects of granulocyte and monocytes adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci 2002; 47: 1334-41.
20. Tsukada Y, Nakamura T, Iimura M, et al. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis. Am J Gastroenterol 2002; 97: 2820-8.
21. Saniabadi AR, Hanai H, Takeuchi K, et al. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial 2003; 7: 48-59.
22. Hanai H, Watanabe F, Takeuchi K, et al. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol 2003; 1: 28-35.
23. Sutherland IR, Martin F, Greer S, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987; 92: 1984-8.
24. Rizzello F, Gionchetti P, D'Arienzo A, et al. Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study. Aliment Pharmachol Ther 2002; 16: 1109-16.
25. Saverymuttu SH, Camilleri M, Rees H, et al. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease: a comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology 1986; 90: 1121-8.
26. Gionchetti P, Ardizzone S, Benvenuti ME, et al. A new mesalazine l enema in the treatment of left-sided ulcerative colitis: randomized controlled multicentre trial. Aliment Pharmacol Ther 1999; 13: 381-8.